The biliary epithelium presents antigens to and activates natural killer T cells

Cholangiocytes express antigen‐presenting molecules, but it has been unclear whether they can present antigens. Natural killer T (NKT) cells respond to lipid antigens presented by the major histocompatibility complex class I‐like molecule CD1d and are abundant in the liver. We investigated whether cholangiocytes express CD1d and present lipid antigens to NKT cells and how CD1d expression varies in healthy and diseased bile ducts. Murine and human cholangiocyte cell lines as well as human primary cholangiocytes expressed CD1d as determined by flow cytometry and western blotting. Murine cholangiocyte cell lines were able to present both exogenous and endogenous lipid antigens to invariant and noninvariant NKT cell hybridomas and primary NKT cells in a CD1d‐dependent manner. A human cholangiocyte cell line, cholangiocarcinoma cell lines, and human primary cholangiocytes also presented exogenous CD1d‐restricted antigens to invariant NKT cell clones. CD1d expression was down‐regulated in the biliary epithelium of patients with late primary sclerosing cholangitis, primary biliary cirrhosis, and alcoholic cirrhosis compared to healthy controls. Conclusions: Cholangiocytes express CD1d and present antigens to NKT cells and CD1d expression is down‐regulated in diseased biliary epithelium, findings which show that the biliary epithelium can activate an important lymphocyte subset of the liver. This is a potentially important immune pathway in the biliary system, which may be capable of regulating inflammation in the context of biliary disease. (Hepatology 2015;62:1249‐1259)

[1]  A. Kaser,et al.  Protective mucosal immunity mediated by epithelial CD1d and IL-10 , 2014, Nature.

[2]  Vincenzo Cerundolo,et al.  Biology of CD1- and MR1-restricted T cells. , 2014, Annual review of immunology.

[3]  P. Kubes,et al.  Immune surveillance by the liver , 2013, Nature Immunology.

[4]  M. Fischbach,et al.  Production of α-Galactosylceramide by a Prominent Member of the Human Gut Microbiota , 2013, PLoS biology.

[5]  Chyung-Ru Wang,et al.  The Functions of Type I and Type II Natural Killer T Cells in Inflammatory Bowel Diseases , 2013, Inflammatory bowel diseases.

[6]  P. Brennan,et al.  Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions , 2013, Nature Reviews Immunology.

[7]  G. Hirschfield,et al.  The immunobiology and pathophysiology of primary biliary cirrhosis. , 2013, Annual review of pathology.

[8]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[9]  R. Siebert,et al.  Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function , 2012, Science.

[10]  V. Nizet,et al.  Invariant NKT cells recognize glycolipids from pathogenic Gram-positive bacteria , 2011, Nature Immunology.

[11]  M. Smyth,et al.  Presumed guilty: natural killer T cell defects and human disease , 2011, Nature Reviews Immunology.

[12]  G. Hirschfield,et al.  Pathogenesis of cholestatic liver disease and therapeutic approaches. , 2010, Gastroenterology.

[13]  T. Karlsen,et al.  Update on primary sclerosing cholangitis. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[14]  R. Tucker,et al.  Cholangiocytes as immune modulators in rotavirus‐induced murine biliary atresia , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[15]  P. Savage,et al.  Liver Autoimmunity Triggered by Microbial Activation of Natural Killer T Cells , 2008, Cell host & microbe.

[16]  I. Wilson,et al.  Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria , 2006, Nature Immunology.

[17]  B. Beutler,et al.  Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections , 2005, Nature.

[18]  D. Adams,et al.  CXC Chemokine Ligand 16 Promotes Integrin-Mediated Adhesion of Liver-Infiltrating Lymphocytes to Cholangiocytes and Hepatocytes within the Inflamed Human Liver1 , 2005, The Journal of Immunology.

[19]  Jiexiong Feng,et al.  The aberrant expression of HLA-DR in intrahepatic bile ducts in patients with biliary atresia: an immunohistochemistry and immune electron microscopy study. , 2004, Journal of pediatric surgery.

[20]  N. Afdhal,et al.  Hepatic CD1d Expression in Hepatitis C Virus Infection and Recognition by Resident Proinflammatory CD1d-Reactive T Cells1 , 2004, The Journal of Immunology.

[21]  T. Shimosegawa,et al.  Evaluation of differential gene expression by microarray analysis in small and large cholangiocytes isolated from normal mice , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[22]  L. Bry,et al.  Mechanism of CD1d-restricted natural killer T cell activation during microbial infection , 2003, Nature Immunology.

[23]  R. Hershberg,et al.  Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. , 2003, Gastroenterology.

[24]  R. Blumberg,et al.  Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. , 2002, Immunity.

[25]  M. Kronenberg,et al.  Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes , 2001, Nature Medicine.

[26]  A. Chott,et al.  CD1d structure and regulation on human thymocytes, peripheral blood T cells,B cells and monocytes , 2000, Immunology.

[27]  S. Porcelli,et al.  Murine CD1d-restricted T cell recognition of cellular lipids. , 2000, Immunity.

[28]  M. Brenner,et al.  Diverse TCRs recognize murine CD1. , 1999, Journal of immunology.

[29]  K. Tsuneyama,et al.  Increased cd1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis , 1998, Hepatology.

[30]  Hiroshi Sato,et al.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. , 1997, Science.

[31]  J. Wilson,et al.  Immunogenicity of biliary epithelium: Investigation of antigen presentation to CD4+ T cells , 1996, Hepatology.

[32]  T. Kudo,et al.  Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1. , 1995, The Tohoku journal of experimental medicine.

[33]  R. Perrone,et al.  Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines. , 1994, The American journal of physiology.

[34]  S. Balk,et al.  Tissue distribution of the non-polymorphic major histocompatibility complex class I-like molecule, CD1d. , 1993, Immunology.

[35]  M. Kojiro,et al.  Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (KMBC) , 1992, Cancer.

[36]  J. Neuberger,et al.  Biliary epithelial cells from the liver of patients with primary biliary cirrhosis: Isolation, characterization, and short‐term culture , 1990, The Journal of pathology.

[37]  D. Jewell,et al.  Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. , 1988, Gut.

[38]  M. Kojiro,et al.  Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude mice , 1987, Hepatology.

[39]  D. V. van Thiel,et al.  INDUCTION OF DR/IA ANTIGENS IN HUMAN LIVER ALLOGRAFTS: AN IMMUNOCYTOCHEMICAL AND CLINICOPATHOLOGIC ANALYSIS OF TWENTY FAILED GRAFTS , 1985, Transplantation.

[40]  W. Dippold,et al.  Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. , 1985, Journal of hepatology.

[41]  A. McMichael,et al.  Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody. , 1981, Gut.

[42]  E. Schrumpf,et al.  Sclerosing cholangitis in ulcerative colitis. , 1980, Scandinavian journal of gastroenterology.